Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-17

Clinical Trial Update: Inhibin B/FSH Ratio as a Predictor of Testicular Pathology in NOA

View source ↗

Summary

A completed clinical trial investigates whether the inhibin B to FSH ratio can predict testicular pathology in men with non-obstructive azoospermia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Elazıg Fethi Sekin Sehir Hastanesi | Conditions: Azoospermia, Nonobstructive, Non-obstructive Azoospermia | Status: COMPLETED